Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters License Agreement with California Cannabis Beverage Maker
Lexaria and GP Holdings LLC enter into a five-year semi-exclusive licensing agreement Lexaria and GP have developed a series of high-performing cannabis beverages with nearly zero unwanted taste and odor California cannabis-beverage market is expected to be one of the largest edible product segments Drug delivery innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) recently announced a definitive technology licensing agreement with GP Holdings LLC to empower next-generation performance in high absorption, fast acting cannabis-infused beverages to be developed and sold in California. DehydraTECH™ is LXRP’s edible delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness…